ODAC | International Myeloma Foundation

ODAC-MRD vote

Week in Review

April 18

FDA Panel Backs MRD Testing to Speed Myeloma Drugs

What concerns about the early use of CAR-T therapy were addressed in the ODAC hearing?

April 4

What concerns about the early use of CAR-T therapy were addressed in the ODAC hearing?

add blog fda envelope original

Week in Review

July 16

Good News: FDA Panel Votes to Approve Belantamab Mafodotin

A panel of people under a projection screen

Week in Review

February 27

ODAC Votes Against Accelerated Approval for Selinexor

FDA stamp of approval

Week in Review

February 26

FDA Reverses ODAC Vote and Approves Panobinostat (Farydak®) for Relapsed Myeloma

Judge's Gavel and stethoscope

Week in Review

November 5

Surprise rejection of panobinostat for approval by 5-2 margin at ODAC Hearing

Bronze statue in front of law books

Week in Review

October 7

Pomalidomide Update

Subscribe to ODAC

Give Where Most Needed